SB4426 - Promising Pathway Act 2.0
US Congress - 118th Congress
Introduced byMike Braun, Kirsten E. Gillibrand, Kevin Cramer
Last updated 4 months ago
12 Co-Sponsors
A bill to amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
STATUS
Introduced
#healthVerifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now